معرفی
Mikkel Koed Møller Aasted is a Postdoctoral Researcher at the University of Copenhagen's Faculty of Health and Medical Sciences within the Department of Cellular and Molecular Medicine and Glycomics Program. His research focuses on the intersection of glycobiology and cancer, utilizing advanced techniques including CRISPR screening, mass spectrometry, and glycoproteomics to investigate aberrant glycosylation patterns in tumors.
His primary research interests include cancer glycomics, aberrant O-glycosylation, CRISPR-based functional genomics, and glycoproteomic analysis. His work specifically targets truncated O-glycans, sialic acid modifications, and zinc homeostasis in tumor glycosylation, with implications for cancer biomarker discovery and therapeutic development. Recent publications demonstrate expertise in developing innovative methods for glycan isomer profiling and spatial manipulation of glycosylation.
Awarded no specific honors mentioned in available data, his research has generated significant academic attention with multiple publications receiving >25 citations. His collaborative network centers around the Wandall laboratory, with frequent co-authorship on high-impact cancer glycomics studies. He maintains active research in developing glycan-targeted cancer therapeutics and diagnostic approaches, particularly focusing on immunotherapeutic applications of tumor-specific glycosylation patterns.
